Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-9-1
pubmed:abstractText
This study compared the effects of the human 70-kDa stress protein (Hsp70) peptide, TKDNNLLGRFELSG (TKD), proinflammatory cytokines, or a combination of both on the repertoire of receptors expressed by human natural killer (NK) cells and their capacity to kill human CX colon carcinoma cells, K562 erythroleukemic cells, and leukemic blasts from two patients with acute myelogenous leukemia. Low-dose interleukin (IL) 2/IL-15 and TKD increase the expression density of activatory (NKG2D, NKp30, NKp44, NKp46, CD94/NKG2C) and inhibitory (CD94/NKG2A) receptors on NK cells. Concomitantly, IL-2/TKD treatment enhances the cytotoxicity of NK cells (as reflected by their secretion of granzyme B) against Hsp70 membrane-positive and human leukocyte antigen (HLA)-E membrane-negative (Hsp70(+)/HLA-E(-)) CX(+) and K562 cells. However, it had no effect on the responsiveness to Hsp70(-)/HLA-E(-) CX(-) cells over that induced by IL-2 alone. The cytotoxicity of IL-2/TKD-activated, purified NK cells and peripheral blood mononuclear cells against Hsp70(+)/HLA-E(+) leukemic blasts was weaker than that against Hsp70(+)/HLA-E(-) K562 cells. Hsp70-blocking and HLA-E transfection experiments confirmed membrane-bound Hsp70 as being a recognition/activatory ligand for NK cells, as cytotoxicity was reduced by the presence of the anti-Hsp70 monoclonal antibody cmHsp70.2 and by inhibiting Hsp70 synthesis using short interference ribonucleic acid. HLA-E was confirmed as an inhibitory ligand, as the extent of NK cell-mediated lysis of K562 cell populations that had been transfected with HLA-E(R) or HLA-E(G) alleles was dependent on the proportion of HLA-E-expressing cells. These findings indicate that Hsp70 (as an activatory molecule) and HLA-E (as an inhibitory ligand) expression influence the susceptibility of leukemic cells to the cytolytic activities of cytokine/TKD-activated NK cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-10358776, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-10426993, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-10560910, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-10799855, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-11072250, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-11133738, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-11244035, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-11795470, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-12473220, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-12653481, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-12675520, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-12874291, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-15115287, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-16364519, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-16670338, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-17142026, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-2201309, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-2903193, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-7632945, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-7705958, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-9003468, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-9103421, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-9126997, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-9585177, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-9586358, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-9655483, http://linkedlifedata.com/resource/pubmed/commentcorrection/18759005-9742914
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1466-1268
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
221-30
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:18759005-Acute Disease, pubmed-meshheading:18759005-Adenocarcinoma, pubmed-meshheading:18759005-Alleles, pubmed-meshheading:18759005-Antibodies, Monoclonal, pubmed-meshheading:18759005-Colonic Neoplasms, pubmed-meshheading:18759005-Cytotoxicity, Immunologic, pubmed-meshheading:18759005-HLA Antigens, pubmed-meshheading:18759005-HSP70 Heat-Shock Proteins, pubmed-meshheading:18759005-Histocompatibility Antigens Class I, pubmed-meshheading:18759005-Humans, pubmed-meshheading:18759005-Immunologic Surveillance, pubmed-meshheading:18759005-Interleukin-15, pubmed-meshheading:18759005-Interleukin-2, pubmed-meshheading:18759005-K562 Cells, pubmed-meshheading:18759005-Killer Cells, Natural, pubmed-meshheading:18759005-Leukemia, Myeloid, pubmed-meshheading:18759005-Leukocytes, Mononuclear, pubmed-meshheading:18759005-Neoplasm Proteins, pubmed-meshheading:18759005-Neoplastic Stem Cells, pubmed-meshheading:18759005-Peptide Fragments, pubmed-meshheading:18759005-RNA, Small Interfering, pubmed-meshheading:18759005-Recombinant Fusion Proteins, pubmed-meshheading:18759005-T-Lymphocytes, Cytotoxic, pubmed-meshheading:18759005-Transfection
pubmed:year
2008
pubmed:articleTitle
Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells.
pubmed:affiliation
Department of Radiotherapy/ Radiooncology, Klinikum rechts der Isar, Technische Universität München, Ismaningerstrasse 22, Munich, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't